Dupilumab significantly reduced exacerbations and improved lung function in adults with uncontrolled chronic obstructive pulmonary disease (COPD) and type 2 inflammation, based on data from more ...

Patients with COPD continue to suffer from frequent exacerbations as well as from a high symptom burden despite the optimization of inhaled medications. This study is an example of endotyping whereby ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses improvements in lung function observed in patients enrolled in the BOREAS trial.

At 52 weeks, adults with moderate/severe COPD and type 2 inflammation receiving dupilumab vs. placebo showed more improved symptom scores, according to a poster presented at the European ...

When you are living with a chronic lung disease, like chronic obstructive pulmonary disease (COPD), every breath matters and ...

NASHVILLE, Tenn. — People with COPD have a greater risk for type 2 myocardial infarction-related admissions and worse in-hospital outcomes, researchers reported at the CHEST Annual Meeting.

Researchers at the University of Pennsylvania have discovered a new type of cell in the human lung. Named respiratory airway secretory cells (RASCs), they seem to play a role in regenerating other ...

Medically reviewed by Daniel More, MD Oxygen therapy for COPD is a treatment used to increase the oxygen in your lungs and bloodstream. Research suggests that people with chronic obstructive ...